Clinical Trial Update: Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the immunogenicity and safety of concomitant administration of a Tdap vaccine with a meningococcal ACWY conjugate vaccine in healthy i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease
• Meningococcal Meningitis

Drugs mentioned

• Menveo (meningococcal group A, C, W-135 and Y conjugate vaccine)
• Tdap vaccine (Diphtheria, tetanus, and pertussis vaccine (Tdap))

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Disease, Meningococcal Meningitis | Phase 3 | Status: COMPLETED | Results posted: 2014-06-18